Answers are grounded in this paper and cite their sources.
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive lethal malignancy that accounts for more than 90% of pancreatic cancer diagnoses. Our research is focused on the physico-chemical properties of the tumour microenvironment (TME), including its tumoural extracellular matrix (tECM) and its impact on the development of new therapies.
No takes yet. Share an insight, caveat, or question.
Calderón-Villalba et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: